| UCSF Magazine

New Drug With UCSF Roots Has Revolutionized Pancreatic Cancer Care

Andrew Ko, who led UCSF's trials of daraxonrasib based on discovery science, tells what to know about the medicine, the science behind it and what it means for patients. . On the heels of the drug's FDA approval, he

For Early Prostate Cancer, 'Active Surveillance' is Now the Number 1 Choice

Geriatrician Says Her Healthiest Patients in Their 70s and Older All Avoid This 1 Thing

Can Antihistamines Really Help With PMDD and Menopausal Symptoms?

In Social Media Addiction Trial, Witness Testifies Meta Took “Don’t Ask Don’t Tell Approach”

What It Was Like to Go Through a Trial That Could Revolutionize Cancer Treatment

F.D.A. Approves Drug Poised to Transform Care for Pancreatic Cancer

Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era

UCSF researchers helped test the first personalized mRNA cancer vaccine shown to prevent melanoma from returning or spreading, marking a breakthrough in cancer treatment.

Meta Settlement Puts Spotlight on Social Media Addiction in Kids

Jason Nagata, MD, MSc, discusses the health dangers of excessive social media use on the health of children, in response to an August 2026 announcement of a $17.1 billion settlement regarding children and teen addiction to their platform.

UCSF-Led Group Awarded $9 Million for Heart Inflammation Research

An international research network led in North America by UC San Francisco (UCSF) has received a $9 million award from the Leducq Foundation, a cardiovascular research funding organization, to uncover how the immune system attacks the heart and develop more precise treatments for myocarditis and other inflammatory heart muscle diseases.

Subscribe to